Flow Cytometric Enumeration of Monocyte and Dendritic Cell Subpopulations: A Study into the Innate Immune System
Translated title
Flow Cytometric Enumeration of Monocyte and Dendritic Cell Subpopulations
Author
Høegh Christensen, Maja
Term
4. term
Publication year
2012
Pages
64
Abstract
IgA‑nefropati (IgAN), også kaldet Bergers sygdom, er den mest almindelige betændelse i nyrernes filterenheder globalt. Sygdommen rammer ofte voksne i 20’erne og 30’erne og forekommer omtrent dobbelt så hyppigt hos mænd som hos kvinder. Den præcise årsag er ukendt, men en form af antistoffet IgA1 med for lidt galaktose ser ud til at udløse sygdommen. Fordi de underliggende immunprocesser ikke er fuldt forstået, findes der endnu ingen målrettede behandlinger; behandlingen fokuserer mest på generelle tiltag som at kontrollere blodtrykket. I dette studie undersøgte vi dele af det medfødte immunsystem ved IgAN. Vi brugte multicolor flowcytometri—en laboratoriemetode, der mærker celler med fluorescerende antistoffer, så de kan identificeres og tælles—til at kortlægge undergrupper af immunceller i blod (monocytter og dendritceller) fra patienter og raske frivillige, og vi ledte efter monocytter i urin. Vi målte overflademarkører for immun sansning og aktivering (TLR4 og HLA‑DR). Monocyt‑undergrupperne var klassiske, intermediære og ikke‑klassiske; dendritcelle‑typerne omfattede plasmacytoide (CD303+) og myeloide (CD1c+ og CD141+). Disse detaljerede undergrupper er først for nylig blevet defineret, og deres fordeling i blod har ikke tidligere været profileret ved IgAN. Vi kunne påvise og tælle alle disse celleundergrupper hos alle deltagere. Monocytter blev fundet i urinen hos én patient, men ikke hos raske kontrolpersoner. For dendritceller var HLA‑DR‑niveauer overordnet ens, med højere topværdier af fluorescens hos kontrolpersoner. Blandt monocytter udtrykte den intermediære undergruppe mest HLA‑DR, og intermediære monocytter fra kontrolpersoner udtrykte mere HLA‑DR end tilsvarende celler hos IgAN‑patienter. Vores resultater viser, at multicolor flowcytometri er en anvendelig metode til at profilere det medfødte immunsystem ved IgAN, men omhyggeligt forsøgsdesign er afgørende. Valg af fluorokrom‑konjugerede antistoffer, der minimerer ikke‑specifik binding, og strenge kvalitetskontroller—særligt ved tandemfarvestoffer—er vigtige for pålidelige data. Større studier og tekniske forbedringer kan give dybere indsigt i ændringer i det medfødte immunsystem ved IgAN og støtte udviklingen af målrettede behandlinger.
IgA nephropathy (IgAN), also called Berger’s disease, is the most common inflammation of the kidney’s filtering units worldwide. It mainly affects adults in their 20s and 30s and is about twice as frequent in men as in women. The exact cause is unknown, but a form of the antibody IgA1 with too little galactose on it appears to trigger the disease. Because the underlying immune processes are not fully understood, there are still no specific treatments; care mostly focuses on general measures such as controlling blood pressure. In this study, we examined parts of the innate immune system in IgAN. We used multicolor flow cytometry—a lab method that labels cells with fluorescent antibodies so they can be identified and counted—to map subtypes of immune cells in blood (monocytes and dendritic cells) from patients and healthy volunteers, and we looked for monocytes in urine. We measured cell‑surface markers linked to immune sensing and activation (TLR4 and HLA‑DR). The monocyte subtypes were classical, intermediate, and non‑classical; the dendritic cell types included plasmacytoid (CD303+) and myeloid (CD1c+ and CD141+). These detailed subtypes have only recently been defined, and their distribution in blood had not previously been profiled in IgAN. We were able to detect and count all these cell subtypes in every participant. Monocytes were found in the urine of one patient but not in healthy controls. Among dendritic cells, HLA‑DR levels were broadly similar across participants, with higher peak fluorescence values in controls. Among monocytes, the intermediate subtype showed the highest HLA‑DR expression, and intermediate monocytes from controls had more HLA‑DR than those from IgAN patients. Our findings show that multicolor flow cytometry is a feasible way to profile innate immune cells in IgAN, but careful experimental design is essential. Choosing fluorochrome‑conjugated antibodies that minimize non‑specific binding and using strict quality controls—especially with tandem dyes—are important to obtain reliable data. Larger studies and further technical improvements could deepen understanding of innate immune changes in IgAN and support the development of targeted therapies.
[This abstract was generated with the help of AI]
Documents